MARKER THERAPEUTICS INC. earnings per share and revenue

GX1 earnings per share for the last quarter are -0.37 EUR whereas the estimation was -0.49 EUR which accounts for 24.55% surprise. Company revenue for the same period amounts to 322.69 k EUR despite the estimated figure of 161.34 k EUR. Estimated earnings per share for the next quarter are -0.25 EUR, and revenue is expected to reach 624.00 k EUR. Also watch annual changes over time to get a bigger picture of GX1 earnings per share and revenue dynamics.